$ARQQ

Willcocks Patrick sold $14K of ARQQ

Willcocks Patrick (General Counsel) sold 557 shares of Arqit Quantum Inc. (ARQQ) at $24.47 across 3 trades on 2026-10-02.

Original reporting
SEC EDGAR · Willcocks Patrick
Published Oct 6, 2026, 11:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARQQ
Neutral
high confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQNeutralLow
01

Why it matters

The sale is small and likely reflects personal liquidity needs rather than a change in confidence in ARQQ.

02

Market read

A routine insider sell with limited trading relevance.

03

What to watch

Potential upcoming corporate events not disclosed in the filing.

Relevance 3/10Novelty 3/10Timing: after-hours filing on 2026-10-06

Background

Form 4 filings provide transparent disclosure of insider transactions, used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$ARQQNeutralHigh confidence
Context

General Counsel Willcocks Patrick sold 557 shares for $13.6K via open-market transactions on 2026-10-02, reducing his holdings to 11,204 shares.

Expected impact

likely slight pressure as the market prices in the insider sell

Evidence & confidence

The transaction amount is small relative to market cap and no 10b5-1 plan was used, indicating a discretionary sale.

Market effects

No broader sector impact; the sale is company‑specific.

Limited to investors tracking ARQQ.

Minimal.

Counterpoint

If the insider is reducing exposure ahead of a negative catalyst, the stock could face downside.

Key entities

  • Arqit Quantum Inc.

    US‑listed quantum communications firm (NASDAQ: ARQQ).

  • Willcocks Patrick

    General Counsel and officer of ARQQ.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).